Corneal endothelial dysfunction treatments: Recent advances in non-invasive treatment strategies
Nano Today,
Journal Year:
2025,
Volume and Issue:
63, P. 102740 - 102740
Published: April 4, 2025
Language: Английский
Emerging alternatives to keratoplasty for corneal endothelial cell dysfunction
Current Opinion in Ophthalmology,
Journal Year:
2024,
Volume and Issue:
35(5), P. 415 - 422
Published: June 26, 2024
Purpose
of
review
While
effective
for
treating
endothelial
dysfunction,
keratoplasty
has
shortcomings
including
limited
access
to
donor
tissue
much
the
world.
Thus,
alternative
strategies
are
under
development.
This
explores
main
advancements
achieved
in
this
field
during
2022–2023.
Recent
findings
publications
further
support
validity
intracameral
cultivated
allogeneic
cell
injection
and
Descemet
stripping
only,
while
emphasizing
benefits
adjunctive
Rho-associated
kinase
inhibitor
(ROCKi)
therapy.
New
donor-independent
artificial
implants,
such
as
EndoArt,
show
favorable
results.
Multiple
pharmacologic
agents,
especially
ROCKi,
promise
monotherapies,
yet
none
currently
approved
human
treatment.
regenerative
genetic
therapies
being
investigated
but
all
still
preclinical
stages.
Summary
A
plethora
innovative
alternatives
disease
is
Among
these,
surgical
methods
mainstay
treatment
closest
clinical
application,
though
studies
establish
their
over
needed.
Albeit
promising,
pharmacologic,
regenerative,
approaches
require
validation
farther
from
application.
Language: Английский
17β-Estradiol Stimulates Oxidative Stress Components and Thyroid Specific Genes in Porcine Thyroid Follicular Cells: Potential Differences Between Sexes
Cells,
Journal Year:
2024,
Volume and Issue:
13(21), P. 1769 - 1769
Published: Oct. 25, 2024
17β-estradiol
plays
a
crucial
role
in
regulating
cellular
processes
both
reproductive
and
non-reproductive
tissues,
including
the
thyroid
gland.
It
modulates
oxidative
stress
contributes
to
sexual
dimorphism
diseases,
with
ROS
production,
particularly
H2O2,
generated
by
NOX/DUOX
enzymes.
This
study
aimed
investigate
effects
of
(10
nM
or
100
nM)
on
expression
NOX/DUOX,
thyroid-specific
genes,
endoplasmic
reticulum
(ER)
stress-related
genes
male
female
porcine
follicular
cells.
Expression
studied
was
evaluated
RT-PCR
before
after
treatment
alone
addition
NOX4
inhibitor
(GKT-136901).
Additionally,
level
measured
flow
cytometry
analysis.
Our
results
show
that
significantly
upregulates
TPO,
stimulates
expression,
affecting
redox
state
also
ER
such
as
CHOP.
In
conclusion,
estrogen
excess
may
contribute
disease
development
via
possible
mechanisms
upregulation
key
involved
response
stress,
especially
CHOP,
well
stimulation
system
consequent
overproduction.
These
play
certain
higher
prevalence
diseases
women.
Language: Английский